A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy

Clinical trial NCT07498426 · RECRUITING

Trial details

NCT number: NCT07498426
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)

Start date: 2026-06-03
Primary completion: 2029-07-20
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.